{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:03:37Z","timestamp":1756425817629,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2025,5,11]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>We present the case of a woman in her late 40s who presented with an iris lesion extending to the ciliary body and mature white cataract with a visual acuity of perception of light in her right eye. The tumour was managed with Bhabha Atomic Research Centre Iodine-125 (BARC I-125) Ocu-Prosta seeds plaque therapy with the amniotic membrane buffer technique. No corneal complications or secondary glaucoma were seen over a 6-month follow-up, and a reduction in tumour size was observed on MRI. Ten months post corneoscleral plaque brachytherapy (PB), the patient underwent phacoemulsification in the same eye and achieved a best corrected visual acuity of 20\/40. This case highlights the use of cost-effective indigenous I-125 Ocu-Prosta seeds with amniotic membrane in the successful management of iridociliary melanoma, which has not been reported so far.<\/jats:p>","DOI":"10.1136\/bcr-2023-255721","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T23:25:30Z","timestamp":1748301930000},"page":"e255721","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Corneoscleral plaque brachytherapy using \u2018BARC I-125 Ocu-Prosta seeds\u2019 in the management of iridociliary melanoma"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8504-8377","authenticated-orcid":false,"given":"Ujjwal Prakash","family":"Jha","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8770-6799","authenticated-orcid":false,"given":"Subina","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Jindal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"2025082802464211000_18.5.e255721.1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12886-021-02236-3","article-title":"Topography and clinical features of iris melanoma","volume":"22","author":"Krohn","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"2025082802464211000_18.5.e255721.2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ophtha.2010.09.018","article-title":"Iris melanoma","volume":"118","author":"Hood","year":"2011","journal-title":"Ophthalmology"},{"key":"2025082802464211000_18.5.e255721.3","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.286"},{"key":"2025082802464211000_18.5.e255721.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2011.10.012"},{"key":"2025082802464211000_18.5.e255721.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(98)00039-7"},{"key":"2025082802464211000_18.5.e255721.6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000493269","article-title":"Novel Eye Plaque Designs for Brachytherapy of Iris and Ciliary Body Melanoma and the First Clinical Application","volume":"5","author":"Liu","year":"2019","journal-title":"Ocul Oncol Pathol"},{"key":"2025082802464211000_18.5.e255721.7","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.4.531"},{"key":"2025082802464211000_18.5.e255721.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01104-1"},{"key":"2025082802464211000_18.5.e255721.9","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-49-582-551"},{"key":"2025082802464211000_18.5.e255721.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.11.038"},{"key":"2025082802464211000_18.5.e255721.11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5114\/jcb.2021.103586","article-title":"Plaque brachytherapy in iris and iridociliary melanoma: a systematic review of efficacy and complications","volume":"13","author":"Karimi","year":"2021","journal-title":"J Contemp Brachytherapy"},{"key":"2025082802464211000_18.5.e255721.12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ophtha.2012.06.053","article-title":"Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes","volume":"120","author":"Shields","year":"2013","journal-title":"Ophthalmology"},{"key":"2025082802464211000_18.5.e255721.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.08.007"},{"key":"2025082802464211000_18.5.e255721.14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5114\/jcb.2019.87407","article-title":"Complications and adverse events of plaque brachytherapy for ocular melanoma","volume":"11","author":"Peddada","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"2025082802464211000_18.5.e255721.15","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4103\/ijo.IJO_3661_20","article-title":"Short-term changes of cornea and tear film after ruthenium-106 plaque therapy for intraocular tumors","volume":"69","author":"Aghaei","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"2025082802464211000_18.5.e255721.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)02241-9"},{"key":"2025082802464211000_18.5.e255721.17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.eye.6701361","article-title":"125I plaque brachytherapy for anterior uveal melanomas","volume":"18","author":"Lumbroso-Le Rouic","year":"2004","journal-title":"Eye (Lond)"},{"key":"2025082802464211000_18.5.e255721.18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0301-4738.98708","article-title":"Episcleral plaque brachytherapy using 'BARC I-125 Ocu-Prosta seeds' in the treatment of intraocular tumors: a single-institution experience in India","volume":"60","author":"Shah","year":"2012","journal-title":"Indian J Ophthalmol"},{"key":"2025082802464211000_18.5.e255721.19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrs.2017.12.019","article-title":"Outcomes of cataract surgery in eyes with ocular melanoma treated with iodine-125 brachytherapy","volume":"44","author":"Bozkurt","year":"2018","journal-title":"J Cataract Refract Surg"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-255721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:46:51Z","timestamp":1756374411000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-255721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,26]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bcr-2023-255721"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-255721","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}